A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Clinical trial NCT06693895 · RECRUITING
Trial details
- NCT number
- NCT06693895
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-26
- Primary completion
- 2026-11-23
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.